149 related articles for article (PubMed ID: 23212393)
1. Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide.
Grant LM; Kleiner DE; Conjeevaram HS; Vuppalanchi R; Lee WM
Dig Dis Sci; 2013 May; 58(5):1415-21. PubMed ID: 23212393
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in the Histopathology of Drug-Induced Liver Injury.
Kleiner DE
Surg Pathol Clin; 2018 Jun; 11(2):297-311. PubMed ID: 29751876
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced cholestatic hepatitis: how late can it occur even after the cessation of the culpable drug?
Zamani N; Mohammad Alizadeh A
Neuro Oncol; 2012 Jul; 14(7):830. PubMed ID: 22544734
[No Abstract] [Full Text] [Related]
4. Temozolomide: fatal hepatic failure.
Prescrire Int; 2014 Sep; 23(152):214. PubMed ID: 25325123
[No Abstract] [Full Text] [Related]
5. Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature.
Grieco A; Tafuri MA; Biolato M; Diletto B; Di Napoli N; Balducci N; Vecchio FM; Miele L
Medicine (Baltimore); 2015 Mar; 94(12):e476. PubMed ID: 25816026
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide.
Neyns B; Hoorens A; Stupp R
Acta Neurol Belg; 2008 Dec; 108(4):131-4. PubMed ID: 19239041
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide induced liver injury.
Dixit S; Hingorani M; Afzal P; Campbell AP
Acta Neurol Belg; 2011 Sep; 111(3):249-51. PubMed ID: 22141295
[TBL] [Abstract][Full Text] [Related]
8. Acute temozolomide induced liver injury: mixed type hepatocellular and cholestatic toxicity.
Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
Acta Gastroenterol Belg; 2016; 79(2):363-365. PubMed ID: 27821033
[TBL] [Abstract][Full Text] [Related]
9. Acute temozolomide induced liver injury : Mixed type hepatocellular and cholestatic toxicity.
Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
Acta Gastroenterol Belg; 2016; 79(4):487-489. PubMed ID: 28209108
[TBL] [Abstract][Full Text] [Related]
10. Acute liver injury induced by levetiracetam and temozolomide co-treatment.
Khoury T; Chen S; Abu Rmeileh A; Daher S; Yaari S; Benson AA; Cohen J; Mizrahi M
Dig Liver Dis; 2017 Mar; 49(3):297-300. PubMed ID: 28034663
[TBL] [Abstract][Full Text] [Related]
11. Treatment-related Acute Myeloid Leukaemia After Temozolomide for Glioblastoma Multiforme.
Tan CW; See SJ; Tham CK; Ang AL
Ann Acad Med Singap; 2014 Jun; 43(6):334-7. PubMed ID: 25028145
[No Abstract] [Full Text] [Related]
12. [Phototoxicity of dacarbazine (Deticene) not reinduced by temozolomide (Temodal)].
Schmutz JL; Barbaud A; Trechot P
Ann Dermatol Venereol; 2006 May; 133(5 Pt 1):500. PubMed ID: 16760848
[No Abstract] [Full Text] [Related]
13. Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.
Mason M; Adeyi O; Fung S; Millar BA
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432915
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide-Associated Liver Fibrosis.
Parakh S; Hamid A; Cher L; Gan HK
J Clin Pharmacol; 2016 Nov; 56(11):1448-1449. PubMed ID: 27094014
[No Abstract] [Full Text] [Related]
15. 10 questions about temozolomide and the treatment of brain tumors.
Pruitt AA; Rosenfeld MR
Neurologist; 2005 Nov; 11(6):362-5. PubMed ID: 16286879
[No Abstract] [Full Text] [Related]
16. Hemorrhagic cystitis as an unexpected adverse reaction to temozolomide: case report.
Islam R; Isaacson BJ; Zickerman PM; Ratanawong C; Tipping SJ
Am J Clin Oncol; 2002 Oct; 25(5):513-4. PubMed ID: 12393995
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide-associated myelodysplasia 6 years after treatment of a patient with pancreatic neuroendocrine tumor.
Rashidi A; Sorscher SM
Leuk Lymphoma; 2015; 56(8):2468-9. PubMed ID: 25530344
[No Abstract] [Full Text] [Related]
18. An analysis of temozolomide-related adverse drug reactions reported to the medicines and healthcare products regulatory agency through the yellow card scheme aiming to characterise idiosyncratic profound bone marrow suppression tantamount to aplastic anaemia.
Dixit S; Hingorani M; Allgar V
Clin Oncol (R Coll Radiol); 2014 Feb; 26(2):120-1. PubMed ID: 24183933
[No Abstract] [Full Text] [Related]
19. Temozolomide (Temodar).
Wesolowski JR; Rajdev P; Mukherji SK
AJNR Am J Neuroradiol; 2010 Sep; 31(8):1383-4. PubMed ID: 20538821
[TBL] [Abstract][Full Text] [Related]
20. Dacarbazine but not temozolomide induces phototoxic dermatitis in patients with malignant melanoma.
Treudler R; Georgieva J; Geilen CC; Orfanos CE
J Am Acad Dermatol; 2004 May; 50(5):783-5. PubMed ID: 15097966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
